Young athletes from higher income families are more likely to specialize in one sport, and also more likely to suffer serious overuse injuries such as stress fractures, according to the first study of its kind.
A tumor-suppressing protein acts as a dimmer switch to dial down gene expression. It does this by reading a chemical message attached to another protein that’s tightly intertwined with DNA, a team led by scientists at The University of Texas MD Anderson Cancer Center reported at the AACR Annual Meeting 2014.
Researchers have found that women on antidepressants are more successful at breastfeeding their babies if they keep taking the medication.
The BioZorb™ three-dimensional surgical marker improved the ability of radiation oncologists to target radiation treatment for breast cancer, according to a scientific presentation at the 2014 American Brachytherapy Society (ABS) Annual Meeting.
Researchers will present findings at the AANS Annual Scientific Meeting on the study that sheds light on the basis of neuropathic pain that persists after apparently successful surgery.
A team of researchers has reviewed a nationwide, prospective, longitudinal outcomes database that measures the safety and effectiveness of everyday neurosurgical spine care and will present the findings at the AANS Annual Scientific Meeting.
Researchers from the Geisel School of Medicine at Dartmouth will present a scientific poster on Wednesday, April 9, 2014 at the American Association of Cancer Researchers conference in San Diego, CA. Their study suggests that manipulation of drug dosage and schedules may improve anti-tumor effects of PI3K-inhibitors to target breast cancer tumors. These findings have implications for the optimal strategy to use such drugs in patients, and lay the groundwork for future development of anti-cancer therapeutics.
A physician-scientist from Rutgers Cancer Institute of New Jersey who is studying ways to advance the molecular understanding of breast cancer has received a $181,000 grant to further this research with the aim of identifying new treatment approaches for more aggressive forms of the disease. Vassiliki Karantza, MD, PhD received the award at the Annual Meeting of the AACR held earlier this week in San Diego.
A research team will present the findings at the 82nd AANS Annual Scientific Meeting, reporting significant discrepancies between discharge codes and surgeons’ own diagnoses.
Comprehensive genomic analysis of low-grade brain tumors sorts them into three categories, one of which has the molecular hallmarks and shortened survival of glioblastoma multiforme
Results of a study that revealed significant differences in the tumors by subgroup will be presented at the AANS Annual Scientific Meeting.
At the AANS Annual Scientific Meeting, researchers will present the results of a study to determine the cumulative effects of head impacts as they relate to changes in the brain absent of concussion.
Researchers from the Geisel School of Medicine at Dartmouth will present a scientific poster on Tuesday, April 8, 2014 at the American Association of Cancer Researchers conference in San Diego, CA. The research identifies a potential characteristic for predicting outcome in a deadly form of brain cancer known as glioblastoma multiforme.
A novel compound, COH-SR4, synthesized at City of Hope can target and treat drug-resistant lung cancers.
Four people with paraplegia are able to voluntarily move previously paralyzed muscles as a result of a novel therapy involving electrical stimulation of the spinal cord, according to a study funded in part by the National Institutes of Health and the Christopher & Dana Reeve Foundation.
Stand Up To Cancer (SU2C), The Lustgarten Foundation, and the Fox Family Cancer Research Funding Trust, along with the American Association for Cancer Research (AACR), SU2C’s Scientific Partner, announced the formation of a Dream Team dedicated to pancreatic cancer research during a press event today at the AACR Annual Meeting 2014, held here April 5-9.
Stand Up To Cancer (SU2C) and the Farrah Fawcett Foundation, along with the American Association for Cancer Research (AACR), SU2C’s Scientific Partner, announced the formation of a research team dedicated to HPV-related cancers during a press event today at the AACR Annual Meeting 2014, held here April 5-9. The HPV and Anal Cancer Foundation is supporting the translational research team by making an additional gift to Stand Up To Cancer.
UC San Francisco has been selected to join a national “dream team” on pancreatic cancer, part of a project designed to accelerate treatment and discoveries for one of the most deadly forms of cancer.
Researchers will present findings at the AANS Annual Scientific meeting of their studying testing if Intralaminar thalamic deep brain stimulation (ILN-DBS) could have an effect on dementia and other neurodegenerative diseases that cause severe cognitive dysfunction.
City of Hope researchers found that menopausal hormone therapy use is linked to a lower risk of B-cell non-Hodgkin lymphoma.
Researchers who conducted intraparenchymal transplantation of bone marrow-derived cell therapy in chronic stroke patients will present their findings at the AANS Annual Scientific Meeting.
Research from Rutgers Cancer Institute of New Jersey shows genomic profiling identifies genomic alterations in tumors that can be associated with targeted treatments for rare and poor prognosis cancers. Preliminary results are being presented this week at the American Association for Cancer Research annual meeting.
During a presentation during the 82nd AANS Annual Scientific Meeting, researchers highlighted the results of research that explores whether 5 aminolevulinic-acid fluorescence (5-ALA) offers additional detection benefits compared to intraoperative MRI (iMRI) when dealing with invasive tumors.
Researchers at the Geisel School of Medicine at Dartmouth have found that the body’s immune system response was enhanced when they disrupted VISTA, a protein that prevents the immune system from overreacting. Understanding how checkpoint regulators like VISTA function is important to cancer researchers, who hope to use the immune system to attack tumors.
A team of City of Hope researchers, lead by Yani Lu, Ph.D., found that a parent’s age at birth, particularly a father’s age, may affect the adult-onset cancer risk for daughters — especially for breast cancer.
New research by Canadian sports medicine physician Mark Tarnopolsky, MD, PhD, suggests that a person can slow the speed at which they age by exercising regularly.
As an emphasis on competitive success in youth sports has led to intense training, frequent competition and early single sport specialization, overuse injuries and burnout have become common. Given these concerns, the American Medical Society for Sports Medicine (AMSSM) released a new clinical report earlier this year that provides guidance to physicians and healthcare professionals who provide care for young athletes.
In a presentation exploring the promise of magnetic nanoparticle (mNP) hyperthermia in breast cancer treatment, Dartmouth researcher P. Jack Hoopes, DMV, PhD, will review preclinical studies conducted at Norris Cotton Cancer Center and discuss plans for early-phase clinical studies in humans at AACR annual meeting on Sunday 4/6/14.
Roswell Park will present findings from 3 studies of Jasco Pharmaceuticals’s JP_11646 at the AACR Annual Meeting 2014. The results show that the novel PIM inhibitor shows promise for treating pancreatic cancer, bladder cancer and acute leukemias.
Variations in a woman’s genome may contribute to her risk of developing ovarian cancer. Researchers using data collected by the Ovarian Cancer Association Consortium have discovered uncommon variants in new regions of the genome that influence ovarian cancer risk, and will present their findings on April 6, 2014 at the American Association for Cancer Research Annual Meeting in San Diego, CA.
Think having a hernia repaired is going to be a walk in the park — or that you’ll be ready to take a walk in the park within hours afterward? It may be time for a reality check, a Mayo Clinic study suggests. Researchers found that though patients tend to expect to return to normal activities swiftly after laparoscopic ventral hernia repair, many of those studied were still experiencing pain and fatigue several days later. People under 60 and women in particular seemed to have more prolonged recoveries.
Ludwig Cancer Research previewed today the full scope of discoveries to be presented by Ludwig scientists at the American Association for Cancer Research (AACR) Annual Meeting next week (April 5 – 9) in San Diego, Calif. Ludwig researchers will deliver two-dozen presentations, and chair or participate in several symposia, educational sessions and meet-the-expert sessions.
Poor blood pressure control among patients with atrial fibrillation is associated with a 50-percent increased risk of stroke, according to an analysis presented by Duke Medicine researchers.
A new study by researchers at Rutgers Robert Wood Johnson Medical School indicates that statin medication prescribed to lower cholesterol and decrease the chance of having a heart attack and stroke, also improves a man’s erectile function.
The National Comprehensive Cancer Network® (NCCN®) will host Designing Clinical Trials in the Era of Multiple Biomarkers and Targeted Therapies on April 25, 2014 in Bethesda, Maryland, as part of the NCCN Oncology Policy Program.
Nearly 84,000 women each year are diagnosed with a gynecologic cancer, and 29,000 die from one of these diseases. Physician scientists at Rutgers Cancer Institute of New Jersey continue to advance scientific and clinical knowledge in this area and recently presented findings relating to cervical and endometrial cancers during the Society of Gynecologic Oncology’s 45th Annual Meeting on Women’s Cancer this past week.
In a series of studies involving 140 American men and women with liver tumors, researchers at Johns Hopkins have used specialized 3-D MRI scans to precisely measure living and dying tumor tissue to quickly show whether highly toxic chemotherapy – delivered directly through a tumor’s blood supply – is working.
Vanderbilt physicist John Wikswo reported significant progress toward creating “homo minutus” – a benchtop human – on Mar. 26 at the Society of Toxicology meeting in Phoenix. So-called organ-on-a-chip technology is being developed to provide a better and less expensive method of drug and toxicity testing.
Is air pollution connected with increases in obesity, diabetes, and chronic kidney disease? Researchers are providing insight into that question at the Society of Toxicology (SOT) 53rd Annual Meeting and ToxExpo in Phoenix, Ariz.
Toxicologists are revealing new methods and models for estimating infants’ exposure to persistent organic pollutants (POPs) at the Society of Toxicology (SOT) 53rd Annual Meeting and ToxExpo in Phoenix, Ariz.
Members of the media can now register to attend what is shaping up to be the world’s largest endocrine meeting. The joint meeting of the International Society of Endocrinology and the Endocrine Society – ICE/ENDO 2014 – will be held in Chicago, IL on June 21-24, 2014.
Veliparib, an oral cancer drug improves outcomes while minimizing side effects in women with gynecologic cancers who carry a BRCA mutation and whose disease is not responding to other therapies, suggests preliminary research.
Toxicologists are presenting information on the uses of nanotechnology in food and food packaging and the current efforts to assure the safe development of the technology at the Society of Toxicology (SOT) 53rd Annual Meeting and ToxExpo in Phoenix, Ariz.
More awareness about skin cancer is needed for minorities because they believe they are at low risk of developing it, says Henry Ford Hospital dermatologist Diane Jackson-Richards, M.D.
Women with BRCA1 mutations may have an increased risk for developing rare types of aggressive uterine cancer despite having their ovaries and fallopian tubes removed, suggest preliminary findings.
Women with ovarian and other gynecologic cancers live significantly longer when they receive care at hospitals that treat a large number of patients with these conditions, according to research on more than 850,000 women.
Women who had bariatric surgery to lose weight had a 70 percent lower risk of uterine cancer and an even lower risk if they kept the weight off, according to findings of a study based on more than 7 million hospital admissions.
Mount Sinai researchers have linked high levels of exposure to inhaled particulate matter by first responders at Ground Zero to the risk of obstructed sleep apnea and post-traumatic stress disorder (PTSD), both conditions that may impact cardiovascular health.
Researchers from Montefiore Medical Center and the Albert Einstein College of Medicine of Yeshiva University will present findings from studies at the 72nd Annual Meeting of the American Academy of Dermatology.
Press Conference Schedule for the 247th American Chemical Society National Meeting & Exposition, March 16-20, 2014.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right